Ipsen Advisor Group’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-13,215
Closed -$1.24M – 109
2026
Q1
$1.24M Buy
13,215
+576
+5% +$56.4K 0.86% 32
2025
Q4
$1.23M Buy
12,639
+174
+1% +$16.5K 0.87% 33
2025
Q3
$1.1M Buy
12,465
+523
+4% +$45.2K 0.79% 36
2025
Q2
$1.03M Buy
11,942
+590
+5% +$50.8K 0.78% 36
2025
Q1
$1.04M Buy
11,352
+493
+5% +$44.8K 0.89% 32
2024
Q4
$934K Buy
+10,859
New +$1M 0.8% 34

Other funds holding IXJ

Ipsen Advisor Group's IXJ Position: Q2 2026 in Review

Ipsen Advisor Group sold out of iShares Global Healthcare ETF (IXJ) in Q2 2026, closing a stake of 13,215 shares — an estimated $1.24M sold.

Ipsen Advisor Group first reported a position in IXJ in Q4 2024 and held it in 6 quarters. The position peaked at $1.24M in Q1 2026. 305 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Ipsen Advisor Group reported no remaining iShares Global Healthcare ETF position as of Q2 2026 after selling out during the quarter.
  • Ipsen Advisor Group sold 13,215 iShares Global Healthcare ETF shares in Q2 2026, an estimated $1.24M.
  • Ipsen Advisor Group first reported a position in iShares Global Healthcare ETF in Q4 2024 and held it in 6 quarters.
  • Ipsen Advisor Group's iShares Global Healthcare ETF position peaked at $1.24M in Q1 2026.
  • 305 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Ipsen Advisor Group's 13F filing for Q2 2026, filed 29 Jul 2026.